U.S. Home Sales to Stay Sluggish Until Mortgage Rates Move Closer to 6%: Fannie Mae
Old National Bancorp Declares $0.14 Dividend
Shares of Homebuilders Are Trading Higher in Sympathy With Toll Brothers, Which Reported Better-than-expected Q3 Financial Results and Issued Guidance Above Estimates.
BioMarin Appoints New Business Chief and R&D Head
NextEra CEO Talks Up Florida Property Market: A Sunshine State Ray Of Hope?
Wolfe Research Upgrades Meritage Homes to Outperform, Announces $230 Price Target
Meritage Homes Analyst Ratings
$100 Invested In Commercial Metals 5 Years Ago Would Be Worth This Much Today
Analyst Expectations For Terreno Realty's Future
Cytokinetics Cut at Goldman Sachs on Diminished Strategic Interest
Goldman Sachs Downgrades Cytokinetics to Neutral, Lowers Price Target to $60
Taylor Morrison Home Analyst Ratings
Goldman Sachs Maintains Neutral on Terreno Realty, Raises Price Target to $68
Terreno Realty Analyst Ratings
Piper Lists Eight Defensive Biotechs to Face Market Volatility
Cytokinetics Analyst Ratings
23 High-quality Cheap Small-caps With Positive Revisions - BofA
Cytokinetics GAAP EPS of -$1.31 Misses by $0.37, Revenue of $0.25M Misses by $20.71M
Murphy Oil Surpasses Q2 Earnings Expectations, Repurchases $56M Of Stock
Terreno Realty FFO of $0.61 Beats by $0.02, Revenue of $94.25M Beats by $5.42M